|
5beta,6alpha-Bis[4-(benzoylaminomethyl)-1H-1,2,3-triazole-1-ylmethyl]-4,5,6,7-tetrahydro-1H-benzoimidazole-2-amine |
|
Pseudomonas |
Biofilm |
Preclinical (in vitro) |
Huigens RW 3rd, et al. 2009. Org Biomol Chem |
|
Propofol |
Depiction based on curated SMILES
CH
3
H
3
C
CH
3
CH
3
OH
|
Salmonella |
Invasion |
Preclinical (in vitro) |
Ridge Y, et al. 2018. J Appl Microbiol |
|
Mefenamic acid |
Depiction based on curated SMILES
H
3
C
HO
O
CH
3
N
H
|
Salmonella |
Invasion |
Preclinical (in vitro) |
Ridge Y, et al. 2018. J Appl Microbiol |
|
3,4-DIMETHYLBENZOIC ACID |
Depiction based on curated SMILES
CH
3
O
HO
CH
3
|
Salmonella |
TTSS (SPI-1 encode) |
Preclinical (in vitro) |
Peixoto RJM, et al. 2017. Appl Environ Microbiol |
|
(E)-N'-(2,3,4-Trihydroxybenzylidene)benzohydrazide |
Depiction based on curated SMILES
OH
OH
O
HO
N
N
H
|
Escherichia Salmonella |
TTSS (Type III secretion system) TTSS (SPI-1 encode); TTSS (SPI-2 encode) |
Preclinical (in vitro) Preclinical (in vitro) |
Tree JJ, et al. 2009. Infect Immun; Wang D, et al. 2011. J Biol Chem Negrea A, et al. 2007. Antimicrob Agents Chemother |
|
N'-(3,5-Dibromosalicylidene)-4-nitrobenzhydrazide |
Depiction based on curated SMILES
Br
_
O
O
+
N
HO
O
Br
N
N
H
|
Salmonella Yersinia |
TTSS (SPI-1 encode); TTSS (SPI-2 encode) TTSS (Type III secretion system) |
Preclinical (in vitro) Preclinical (in vitro) |
Negrea A, et al. 2007. Antimicrob Agents Chemother Kauppi AM, et al. 2003. Chem Biol; Nordfelth R, et al. 2005. Infect Immun |
|
N'-(3,5-dichloro-2-hydroxybenzylidene)benzohydrazide |
Depiction based on curated SMILES
OH
Cl
O
Cl
N
N
H
|
Escherichia Salmonella |
TTSS (Type III secretion system) TTSS (SPI-1 encode); TTSS (SPI-2 encode) |
Preclinical (in vitro) Preclinical (in vitro) |
Tree JJ, et al. 2009. Infect Immun; Wang D, et al. 2011. J Biol Chem Negrea A, et al. 2007. Antimicrob Agents Chemother |
|
1-Phenyl-3-(1,2,3-thiadiazol-5-yl)urea |
Depiction based on curated SMILES
O
NH
N
H
N
N
S
|
Shigella |
VirF |
Preclinical (in vitro) |
Hurt JK, et al. 2010. J Biomol Screen; Emanuele AA, et al. 2014. J Antibiot (Tokyo); Emanuele AA, et al. 2015. PLoS One |
|
4-(2-(Pyrrolidin-1-yl)ethyl)aniline |
Depiction based on curated SMILES
H
2
N
N
|
Shigella |
TTSS (Type III secretion system) |
Preclinical (in vitro) |
Dey S, et al. 2017. ChemMedChem |
|
5-chloro-N-(3-chloro-4-methoxyphenyl)-2-(methylsulfonyl)pyrimidine-4-carboxamide |
Depiction based on curated SMILES
O
O
CH
3
S
Cl
N
N
O
N
H
Cl
CH
3
O
|
Shigella |
VirF |
Preclinical (in vitro) |
Emanuele AA, et al. 2014. J Antibiot (Tokyo); Emanuele AA, et al. 2015. PLoS One |
|
| | |